FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Denis Soulières

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
A R Abdul Razak; K K Chan; Eric X Chen; S Chia; N Giri; Sebastien J Hotte; S A Laurie; C Le Tourneau; C Mormont; P-F Nguyen-Tan; S Quinn; S Singh; Denis Soulières; T Wang; E Winquist; Lillian L Siu
A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck.
D Ross Camidge; Richard C Chao; Normand Blais; Robert C Doebele; Derek J Jonker; Scott A Laurie; Ana Ruiz-Garcia; Denis Soulières; Aron Thall; Ke Zhang; Laura Q Chow
Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma.
Hugo Villeneuve; Denis Soulières; Tareck Ayad; Apostolos Christopoulos; Philippe Després; David Donath; Edith Filion; Bernard Fortin; Louis Guertin; Phuc Felix Nguyen-Tan
Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Denis Soulières (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: A R Abdul Razak; K K Chan; Eric X Chen; S Chia; N Giri; Sebastien J Hotte; S A Laurie; C Le Tourneau; C Mormont; P-F Nguyen-Tan; S Quinn; S Singh; Denis Soulières; T Wang; E Winquist; Lillian L Siu
A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(3):761-9.
2013: D Ross Camidge; Richard C Chao; Normand Blais; Robert C Doebele; Derek J Jonker; Scott A Laurie; Ana Ruiz-Garcia; Denis Soulières; Aron Thall; Ke Zhang; Laura Q Chow
Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma.
Cancer chemotherapy and pharmacology 2013;71(2):307-19.
2012: Hugo Villeneuve; Denis Soulières; Tareck Ayad; Apostolos Christopoulos; Philippe Després; David Donath; Edith Filion; Bernard Fortin; Louis Guertin; Phuc Felix Nguyen-Tan
Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
International journal of radiation oncology, biology, physics 2012;82(5):1866-71.
2012: Sébastien Clavel; Guila Delouya; Philippe Després; Edith Filion; Bernard Fortin; Louis Guertin; Manon Bélair; Marie-Pierre Charron; Denis Soulières; Phuc Felix Nguyen-Tan
The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer.
International journal of radiation oncology, biology, physics 2012;82(2):567-73.
2012: Sébastien Clavel; Philippe Després; David Donath; Bernard Fortin; Louis Guertin; Nader Khaouam; David H A Nguyen; Denis Soulières; Phuc Felix Nguyen-Tan
Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma.
International journal of radiation oncology, biology, physics 2012;82(2):582-9.
2011: Charles Butts; Yvon Cormier; Peter M Ellis; Martin Falk; Glenwood Goss; Andrew Maksymiuk; Ernie Marshall; Allan Price; Ravinder Sawhney; Denis Soulières; Frank Beier; Nevin Murray
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial.
Journal of cancer research and clinical oncology 2011;137(9):1337-42.
2011: Lilian Amrein; Bertrand J Jean-Claude; Z Rachid; Denis Soulières; Raquel Aloyz; L Panasci
ZRF4, a combi-molecule with increased efficacy as compared with the individual components in chronic lymphocytic leukemia lymphocytes in vitro.
Leukemia 2011;25(9):1512-6.
2011: F Aubin; R Burkes; B Colwell; S Gill; S Kamel-Reid; S Koski; A Pollett; B Samson; M Tehfe; R Wong; S Young; Denis Soulières
Canadian Expert Group consensus recommendations: KRAS testing in colorectal cancer.
Current oncology (Toronto, Ont.) 2011;18(4):e180-4.
2011: Luis Corrales-Rodriguez; Normand Blais; Denis Soulières
Emepepimut-S for non-small cell lung cancer.
Expert opinion on biological therapy 2011;11(8):1091-7.
2011: Sébastien Clavel; Bernard Fortin; Philippe Després; David Donath; Denis Soulières; Nader Khaouam; Danielle Charpentier; Manon Bélair; Louis Guertin; Phuc Felix Nguyen-Tan
Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach.
International journal of radiation oncology, biology, physics 2011;79(3):763-9.
2011: Lilian Amrein; Denis Soulières; James B Johnston; Raquel Aloyz
p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes.
Leukemia research 2011;35(1):99-102.
2010: Charles Butts; R Nevin Murray; Colum J Smith; Peter M Ellis; Kevin Jasas; Andrew Maksymiuk; Glenwood Goss; Guy Ely; Frank Beier; Denis Soulières
A multicenter open-label study to assess the safety of a new formulation of BLP25 liposome vaccine in patients with unresectable stage III non-small-cell lung cancer.
Clinical lung cancer 2010;11(6):391-5.
2010: Levon Igidbashian; Bernard Fortin; Louis Guertin; Denis Soulières; Geneviève Coulombe; Manon Belair; Danielle Charpentier; Jean-Claude Tabet; Phuc Felix Nguyen-Tan
Outcome with neck dissection after chemoradiation for N3 head-and-neck squamous cell carcinoma.
International journal of radiation oncology, biology, physics 2010;77(2):414-20.
2010: Maroie Barkati; Bernard Fortin; Denis Soulières; Sébastien Clavel; Phillipe Després; Danielle Charpentier; Jean-Claude Tabet; Louis Guertin; Marie-Jo Olivier; Geneviève Coulombe; David Donath; Phuc Felix Nguyen-Tan
Concurrent chemoradiation with carboplatin-5-fluorouracil versus cisplatin in locally advanced oropharyngeal cancers: is more always better?
International journal of radiation oncology, biology, physics 2010;76(2):410-6.
2010: Louise Lambert; Bernard Fortin; Denis Soulières; Louis Guertin; Geneviève Coulombe; Danielle Charpentier; Jean-Claude Tabet; Manon Bélair; Nader Khaouam; Phuc Felix Nguyen-Tan
Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding?
International journal of radiation oncology, biology, physics 2010;76(2):398-402.
2010: Luis Paz-Ares; Denis Soulières; Ivan Melezínek; Joachim Moecks; Lorenz Keil; Tony Shu Kam Mok; Rafael Rosell; Barbara Klughammer
Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis.
Journal of cellular and molecular medicine 2010;14(1-2):51-69.
2009: Pierre-Olivier Gaudreau; Xiaoduan Weng; Ghislain Cournoyer; Louise Robin; Carmen Gagnon; Denis Soulières
Treatment with hydroxyurea in a patient compound heterozygote for a high oxygen affinity hemoglobin and beta-thalassemia minor.
American journal of hematology 2009;84(11):766-8.
2009: Lilian Amrein; Lawrence Panasci; Spencer B Gibson; James B Johnston; Denis Soulières; Raquel Aloyz
Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro.
British journal of haematology 2009;147(3):396-8.
2009: Denis Soulières
Advanced renal cell carcinoma: what to do after first line antiangiogenic therapy?
Current opinion in supportive and palliative care 2009;3(3):153-6.
2009: Daniel Taussky; Denis Soulières
Hypofractionated radiotherapy with concomitant sunitinib - is there a radiosensitizing effect?
The Canadian journal of urology 2009;16(2):4599-600.
2009: Tareck Ayad; Louis Guertin; Denis Soulières; Manon Belair; Stéphane Temam; Phuc Felix Nguyen-Tân
Controversies in the management of retromolar trigone carcinoma.
Head & neck 2009;31(3):398-405.
2008: Gilbert Cornut; Claude Fortin; Denis Soulières
Antineoplastic properties of bacteriocins: revisiting potential active agents.
American journal of clinical oncology 2008;31(4):399-404.
2008: John Porter; Renzo Galanello; Giuseppe Saglio; Ellis J Neufeld; Elliott Vichinsky; Maria Domenica Cappellini; Nancy F Olivieri; Antonio Piga; Melody J Cunningham; Denis Soulières; Norbert Gattermann; Gilbert Tchernia; Johan Maertens; Patricia J Giardina; Janet Kwiatkowski; Giovanni Quarta; Michael Jeng; Gian Luca Forni; Michael Stadler; Holger Cario; Louisette Debusscher; Matteo Della Porta; Mario Cazzola; Peter Greenberg; Giuliana Alimena; Bertrand Rabault; Insa Gathmann; John Malcolm Ford; Daniele Alberti; Christian Rose
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.
European journal of haematology 2008;80(2):168-76.
2008: Pierre Chagnon; Luigina Mollica; Claude Belisle; Céline Deveaux; Giovanni D Angelo; Denis-Claude Roy; Denis Soulières; Lambert Busque
Hb Montreal II: a novel elongated beta-globin variant caused by a frameshift mutation [beta142 (-C)].
Hemoglobin 2008;32(4):351-9.
2007: Abdulhadi Aldejmah; Denis Soulières; Fred Saad
Isolated solitary bony metastasis of a nonseminomatous germ cell tumor.
The Canadian journal of urology 2007;14(1):3458-60.
2007: Gilbert Cornut; Xiaoduan Weng; Louise Robin; Catherine Lavoie; Sylvain Marchand; Denis Soulières
A new insertion mutation in the beta-globin gene [codons 45/46 (+A)] resulting in a beta-thalassemia minor phenotype.
Hemoglobin 2007;31(3):393-5.
2006: Véronique-Isabelle Forest; Phuc Félix Nguyen-Tan; Jean-Claude Tabet; Marie-Jo Olivier; Daniel Larochelle; Bernard Fortin; Michel Gélinas; Denis Soulières; Danielle Charpentier; Louis Guertin
Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma.
Head & neck 2006;28(12):1099-105.
2006: Nicolas Charbonneau; Michel Gélinas; Pierre del Vecchio; Louis Guertin; Daniel Larochelle; Jean-Claude Tabet; Denis Soulières; Danielle Charpentier; Phuc Félix Nguyen-Tân
Primary radiotherapy for tonsillar carcinoma: a good alternative to a surgical approach.
The Journal of otolaryngology 2006;35(4):227-34.
2006: Martin E Blackstein; Jean-Yves Blay; Christopher L Corless; David K Driman; Robert H Riddell; Denis Soulières; Carol J Swallow; Shailendra Verma
Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2006;20(3):157-63.
2005: Charles Butts; Nevin Murray; Andrew Maksymiuk; Glenwood Goss; Ernie Marshall; Denis Soulières; Yvon Cormier; Peter Ellis; Allan Price; Ravinder Sawhney; Mary Davis; Janine Mansi; Colum Smith; Dimitrios Vergidis; Paul Ellis; Mary MacNeil; Martin Palmer
Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6674-81.
2005: Tareck Ayad; Michel Gélinas; Louis Guertin; Daniel Larochelle; Pierre del Vecchio; Jean-Claude Tabet; Marie-Jo Olivier; Denis Soulières; Danielle Charpentier; Phuc Félix Nguyen-Tân
Retromolar trigone carcinoma treated by primary radiation therapy: an alternative to the primary surgical approach.
Archives of otolaryngology--head & neck surgery 2005;131(7):576-82.
2005: Roman Perez-Soler; Jean-Pierre Delord; Allan C Halpern; Karen Kelly; James Krueger; Bartomeu Massutí Sureda; Joachim von Pawel; Jennifer S Temel; Salvatore Siena; Denis Soulières; Leonard B Saltz; James Leyden
HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum.
The oncologist 2005;10(5):345-56.
2005: Julie Bergeron; Xiaoduan Weng; Louise Robin; Harold J Olney; Denis Soulières
Prevalence of alpha-globin gene deletions among patients with unexplained microcytosis in a North-American population.
Hemoglobin 2005;29(1):51-60.
2003: Denis Soulières
Identifying predictive and surrogate markers of erlotinib antitumor activity other than rash.
Oncology (Williston Park, N.Y.) 2003;17(11 Suppl 12):29-33.
2003: Karl Bélanger; David MacDonald; Gregory Cairncross; Stan Gertler; Peter A Forsyth; Susan Burdette-Radoux; Julie Bergeron; Denis Soulières; Samuel Ludwin; Nancy Wainman; Elizabeth Eisenhauer
A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma.
Investigational new drugs 2003;21(4):473-80.
2002: Karl Bélanger; Malcolm Moore; Sharyn D Baker; Jeanne Dionne; Martha Maclean; Jacques Jolivet; Lillian Siu; Denis Soulières; Nancy Wainman; Lesley Seymour
Phase I and pharmacokinetic study of novel L-nucleoside analog troxacitabine given as a 30-minute infusion every 21 days.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(10):2567-74.